Live at ViVE: Transforming Life Sciences with Digital Biomarkers—featuring Rich Carter
How do you know if a particular medicine is working?
Traditionally, it takes guesswork on the physician’s part and time to find a drug that works for any given patient.
But what if we could leverage digital biomarkers to measure the efficacy of a medication very quickly and course correct as needed?
Rich Carter serves as Chief Digital Officer at Eli Lilly, where he oversees the teams focused on innovation, user-centered design and digital health.
On this episode of The Beat, Rich joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to discuss the future of drug development and clinical…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.